Walleye Capital’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Walleye Capital’s Portfolio REVBU Stock Details REVBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-177,428	Closed	-$35.5K	–	4680
2022 Q4	$35.5K	Hold	177,428	–	–	﹤0.01%	2587
2022 Q3	$57K	Buy	+177,428	New	+$123K	﹤0.01%	2562
2021 Q1	–	Sell	-72,660	Closed	-$785	–	1426
2020 Q4	$785	Buy	+72,660	New	+$738K	0.05%	349

Walleye Capital's REVBU Position: Q1 2023 in Review

Walleye Capital sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q1 2023, closing a stake of 177,428 shares — an estimated $35.5K sold.

Walleye Capital first reported a position in REVBU in Q4 2020 and held it in 3 quarters. The position peaked at $57K in Q3 2022. 0 funds tracked by Wall St. Rank hold REVBU as of Q1 2023.

Walleye Capital reported no remaining Revelation Biosciences, Inc. Unit position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 177,428 Revelation Biosciences, Inc. Unit shares in Q1 2023, an estimated $35.5K.
Walleye Capital first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 3 quarters.
Walleye Capital's Revelation Biosciences, Inc. Unit position peaked at $57K in Q3 2022.
0 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.